Tasly Pharmaceutical Group Co.,Ltd. Posted 463.5 Million Yuan Net Loss in First Half of 2022

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) (600535.SH) reported a net loss of 463.5 million yuan in the first half of 2022, reversing a net profit of 1 billion yuan for the same period in the previous year.

Meanwhile, the company posted 4 billion yuan in revenue, up 4.8% year-on-year.

At the end of the reporting period, it had 15.7 billion yuan in total assets and 3.3 billion yuan in total liabilities, with a liability-to-asset ratio of 21.3%.